Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2022 - 07 - 25    symbols : Azn    save search

Global Pharmaceutical Drug Delivery Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2022-07-25 (Crawled : 20:00) - prnewswire.com
AZNCF | $135.94 770 twitter stocktwits trandingview |
Health Technology
| | O: 3.39% H: 0.42% C: -1.6%
NVS | $93.07 -1.42% 280K twitter stocktwits trandingview |
Health Technology
| | O: 0.96% H: 0.47% C: -0.08%
JNJ | $144.84 -1.86% 3M twitter stocktwits trandingview |
Health Technology
| | O: 0.14% H: 0.0% C: 0.0%
LLY | $749.58 -0.16% 450K twitter stocktwits trandingview |
Health Technology
| | O: -0.17% H: 0.48% C: 0.17%
ABBV | $163.08 0.87% 500K twitter stocktwits trandingview |
Health Technology
| | O: 1.61% H: 0.0% C: 0.0%
SNY | $45.99 0.13% 70K twitter stocktwits trandingview |
Health Technology
| | O: -0.1% H: 0.0% C: 0.0%
AZN | $68.34 -0.57% 750K twitter stocktwits trandingview |
Health Technology
| | O: 0.62% H: 1.09% C: 0.23%
AMGN | $265.07 -0.17% 280K twitter stocktwits trandingview |
Health Technology
| | O: 0.37% H: 1.66% C: 0.6%

drug global market
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US for patients with HER2-low metastatic breast cancer
Published: 2022-07-25 (Crawled : 12:00) - biospace.com/
AZN | $68.34 -0.57% 750K twitter stocktwits trandingview |
Health Technology
| | O: 1.43% H: 0.39% C: -0.04%

enhertu granted review cancer her2- her2 metastatic breast cancer
ENHERTU® Granted Priority Review in the U.S. for Patients with HER2 Low Metastatic Breast Cancer
Published: 2022-07-25 (Crawled : 11:00) - biospace.com/
AZN | $68.34 -0.57% 750K twitter stocktwits trandingview |
Health Technology
| | O: 1.43% H: 0.39% C: -0.04%

enhertu granted review cancer her2- her2 metastatic breast cancer
Gainers vs Losers
48% 52%

Top 10 Gainers
TPET | $0.4801 107.75% 16M twitter stocktwits trandingview |
n/a

JAGX | $0.23 93.6% 310M twitter stocktwits trandingview |
Health Technology

WISA 4 | $3.17 81.14% 36M twitter stocktwits trandingview |
Electronic Technology

PALI | $6.57 57.93% 19M twitter stocktwits trandingview |
Manufacturing

SPCB | $0.4278 55.0% 17M twitter stocktwits trandingview |
Electronic Technology

BTTR | $7.61 49.22% 1.8M twitter stocktwits trandingview |
Manufacturing

PRSO | $1.79 40.95% 25M twitter stocktwits trandingview |
Manufacturing

DYNT | $0.5203 40.47% 17M twitter stocktwits trandingview |
Health Technology

MCBC | $13.755 38.52% 620K twitter stocktwits trandingview |
Finance

SNGX | $0.5155 33.52% 3.9M twitter stocktwits trandingview |
Health Technology


Your saved searches
Save your searches and get alerts when important news are released.